SG9999014716
SG9999014716
Wave Life Sciences, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 681.79M EUR | 1.12B EUR | 1.39B EUR | 3.19B EUR |
Enterprise Value | 236.75M EUR | 798.52M EUR | 865.57M EUR | 2.61B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -2.99x | -- | -- | -- |
Price to Sales | 10.43x | 17.18x | 19.42x | 95.08x |
Price to Book | 1.47x | 2.48x | 2.72x | 6.15x |
EV/Revenue | 3.62x | 12.22x | 12.06x | 77.67x |
EV/EBITDA | -1.1x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -18.89% | -17.2% | -13.27% | -3.92% |